(Q46466256)

English

Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol

scientific article published on 23 July 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

author name string

K P Kanebratt

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

T Bäckström

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

E Sparve

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

E Bredberg

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

Y Böttiger

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

T B Andersson

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

L Bertilsson

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

language of work or name

0 references

publication date

23 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

84

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

589-594

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Induction of polymorphic 4'-hydroxylation of S-mephenytoin by rifampicin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

The impact of CYP2C9 genetics and oral contraceptives on cytochrome P450 2C9 phenotype

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Pharmacokinetic interactions with rifampicin : clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

CYP induction-mediated drug interactions: in vitro assessment and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: effect of induction by rifampin and ethnicity

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

A potentially significant interaction between efavirenz and phenytoin: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Determination of esomeprazole and its two main metabolites in human, rat and dog plasma by liquid chromatography with tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

21 January 2018

The mechanism of the warfarin-rifampin drug interaction in humans

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

7 January 2021

based on heuristic

inferred from DOI database lookup

Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of omeprazole sulfone in a single plasma sample as a probe for CYP3A4

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of digoxin and main metabolites/derivatives in healthy humans.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.132

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CLPT.2008.132

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18650803

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46466256&oldid=2204786001"